UNSPSC 51102855: Metronidazole/sodium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM900. This VA Drug Class (AM900) classifies this compound as belonging to the group ANTI-INFECTIVES, OTHER.

UNSPSC 51102855 Metronidazole/sodium chloride is a Commodity code that does not align with the recent state and local solicitations tagged under it. The recent opportunities posted under this code—naloxone procurement, therapeutic pharmacy initiatives, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals through cooperative purchasing—concern product categories ranging from emergency medications and OTC pharmaceuticals to complex pharmacy benefit management arrangements. None of these solicitations involve metronidazole or sodium chloride specifically, and the code's nominal scope does not match the actual buying activity being tracked. The mix of issuing bodies includes county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and state-led cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). These entities are procuring emergency-response pharmaceuticals, controlled-substance alternatives, broad-spectrum generic medication programs, and integrated pharmacy supply solutions rather than the specific pharmaceutical compound indicated by the code number.

Geographic activity spans Florida, Texas, Minnesota, and Oregon, with representation across state health systems, municipal emergency services, and multi-state cooperative purchasing vehicles. Recent representative opportunities include Seminole County's competitive bid (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone annually with quarterly deliveries to support community health, the City of Tampa's sheltered-market invitation to bid (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies estimated at $700,000 with a 5 percent small local business enterprise discount, and the Minnesota Multistate Cooperative Purchasing Alliance's request for proposal (S1070000015802, due March 26, 2026) establishing multiple contracts for generic pharmaceuticals and OTC products distributed across state and local facilities. The Texas Health and Human Services Commission also posted an exploratory RFI (HHS0017013) in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs. The code shows significant mismatch between its nominal definition and the procurement activity actually occurring under it, suggesting a potential taxonomy misalignment in how state and local buyers are categorizing pharmaceutical and medical supply solicitations.